The series focuses on outcomes research in chronic kidney disease and end-stage renal disease, delivery of care in dialysis units and chronic kidney disease clinics, emerging data on new treatments compared to current standard of care, continuing review of kidney biopsy pathology, and basic science research that may become future therapeutics.
Key Words: Nephrology, Renal Disease, Kidneys, Acute kidney injuries, Hypertension
- Physician
- Nurse Practitioner
- Physician Assistant
- Nurse
- Medical Students, Trainees
Participants who engage in this educational intervention will be able to:
- Recognize the process and journey to be listed for kidney transplant from both physician and patient perspectives.
- Recognize factors leading to the organ pool shortage and advances to make kidney transplantation more accessible.
- Recognize the use, indications, benefits, and risks of implantable cardiac devices in acute kidney injury.
- Recognize the use, indications, benefits, and risks of implantable cardiac devices in end-stage kidney disease.
- Outline the clinical presentation, histologic findings, and pathophysiology of primary thrombotic microangiopathy.
- Outline the various secondary causes of thrombotic microangiopathy.
- Outline data on the role of supportive therapy for IgA nephropathy.
- Outline data on the role of immunosuppressive therapy for IgA nephropathy.
Speaker:
Dawn Wolfgram, MD
Assistant Professor
Division of Nephrology
Medical College of Wisconsin
Activity Directors:
Dawn Wolfgram, MD
Associate Professor
Department of Medicine
Division of Nephrology
Medical College of Wisconsin
Planning Committee Member(s):
In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.
- Dawn Wolfgram
- Ashraf El-Meanawy
- Bianca Madrid
The following persons in control of content disclosed the following financial relationships which were reviewed via the MCW conflict of interest mitigation process and addressed.
Name | Company | Role |
---|---|---|
Contact
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.